Perineural but not systemic low-dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial
Authors Kawanishi R, Yamamoto K, Tobetto Y, Nomura K, Kato M, Go R, Tsutsumi YM, Tanaka K, Takeda Y
Received 13 December 2013
Accepted for publication 4 February 2014
Published 8 April 2014 Volume 2014:7 Pages 5—9
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Ryosuke Kawanishi,1 Kaori Yamamoto,2 Yoko Tobetto,2 Kayo Nomura,2 Michihisa Kato,2 Ritsuko Go,2 Yasuo M Tsutsumi,3 Katsuya Tanaka,3 Yoshitsugu Takeda4
1Department of Anesthesiology, Tokushima University Hospital, Tokushima, 2Division of Anesthesiology, Tokushima Red Cross Hospital, Komatsushima, 3Department of Anesthesiology, Institute of Health Bioscience, University of Tokushima Graduate School, Tokushima, 4Division of Orthopedics, Tokushima Red Cross Hospital, Komatsushima, Japan
Purpose: To determine the effects of intravenous and perineural dexamethasone on the duration of interscalene brachial plexus block (ISB) with ropivacaine in patients undergoing arthroscopic shoulder surgery.
Patients and methods: In this prospective, randomized, placebo-controlled trial, patients presenting for arthroscopic shoulder surgery with an ISB were randomized to receive ropivacaine 0.75% (group C), ropivacaine 0.75% plus perineural dexamethasone 4 mg (group Dperi), or ropivacaine 0.75% plus intravenous dexamethasone 4 mg (group Div). The primary outcome was the duration of analgesia, defined as the time between performance of the block and the first request for analgesic.
Results: Thirty-nine patients were randomized. The median times of sensory block in groups C, Dperi, and Div were 11.2 hours (interquartile range [IQR] 8.0–15.0 hours), 18.0 hours (IQR 14.5–19.0 hours), and 14.0 hours (IQR 12.7–15.1 hours), respectively. Significant differences were observed between groups Dperi and C (P=0.001). Kaplan–Meier analysis for the first analgesic request showed significant differences between groups Dperi and C (P=0.005) and between groups Dperi and Div (P=0.008), but not between groups C and Div.
Conclusion: Perineural but not intravenous administration of 4 mg of dexamethasone significantly prolongs the duration of effective postoperative analgesia resulting from a single-shot ISB with ropivacaine 0.75%.
Keywords: ropivacaine, interscalene nerve block, dexamethasone, postoperative pain, perineural
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]